Sinoway Industrial Co., Ltd.

Pitavastatina Cálcio 147526-32-7 Pitavastatina Cálcio 147526-32-7

Pitavastatina Cálcio 147526-32-7
Produtos relacionados
  • L-glutationa reduzida (GSH) 70-18-8

    L-Glutationa reduzida Informações básicas de L-glutationa reduzida: nome do produto: L-glutationa fórmula de ReducedMolecular: C20H32N6O12S2Peso molecular: 612.63CAS no .: 70-18-8ENIECE No: 200-725-4Appearanc ...

  • Peptídeo de cobre (GHK) 2-CU 49557-75-7

    Péptido de cobre GHK-CuBasic a informação do peptide de cobre GHK-Cu: Nome de produto (GHK) 2-Cu (Peptide de cobre) SinônimosGHK-Cu (peptide de cobre) CAS # 49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2 ...

  • Isoflavonas em soja 574-12-9

    Extrato do feijão de soja1. Informação básica do extrato do feijão de soja: Nome do produto: ExtratoFonte do feijão de soja: peça do maxUsed do glycine: pulpSpec do germe / feijão: isoflavone total 40%, 80% da soja pelo extrato ...

Informação básica de Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Uso de cálcio de pitavastatina 147526-32-7

  • A pitavastatina cálcica é indicada para hipercolesterolemia (colesterol elevado) e para a prevenção de doenças cardiovasculares.

COA de Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatina Cálcio 147526-32-7

Informação básica de Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Uso de cálcio de pitavastatina 147526-32-7

  • A pitavastatina cálcica é indicada para hipercolesterolemia (colesterol elevado) e para a prevenção de doenças cardiovasculares.

COA de Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Artigos Relacionados
Deixe uma mensagem E-mail

entraremos em contato dentro de 24 horas.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Piso 16, Centro de Negócios Huicheng, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//